DAK HEALTH has floated a tender for Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Ingredient Brodalumab, Atc L04ac12 for the Period November 1St, 2022 - October 31St, 2024. The project location is Germany and the tender is closing on 05 Sep 2024. The tender notice number is -, while the TOT Ref Number is 72037195.
Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.
Procurement Summary
Country : Germany
Summary : Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Ingredient Brodalumab, Atc L04ac12 for the Period November 1St, 2022 - October 31St, 2024
Sign in with Google